# COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device

> **NCT04296318** · — · TERMINATED · sponsor: **Mologic Ltd** · enrollment: 86 (actual)

## Conditions studied

- COPD Exacerbation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04296318
- **Lead sponsor:** Mologic Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2019-11-19
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-07-24
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2022-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04296318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04296318, "COPD Exacerbation Alert System With urinE anaLysis Using the HEADSTART Device". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04296318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*